Quick Answer
InfuSystem Holdings, Inc reported Total Revenue of $143.44 million for the year ending 2025.
- InfuSystem Holdings, Inc showed an increase of +6.4% in Total Revenue from 2024 to 2025.
- This data is from InfuSystem Holdings, Inc's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $17.65 million | Q2 2017: $16.94 million | Q3 2017: $17.59 million | Q1 2018: $16.48 million | Q2 2018: $16.42 million | Q3 2018: $16.68 million | Q1 2019: $18.19 million | Q2 2019: $19.72 million | Q3 2019: $21.49 million | Q1 2020: $21.55 million | Q2 2020: $26.00 million | Q3 2020: $25.13 million | Q1 2021: $24.46 million | Q2 2021: $24.83 million | Q3 2021: $26.57 million | Q1 2022: $26.76 million | Q2 2022: $27.04 million | Q3 2022: $27.28 million | Q1 2023: $30.37 million | Q2 2023: $31.74 million | Q3 2023: $31.91 million | Q1 2024: $32.00 million | Q2 2024: $33.70 million | Q3 2024: $35.32 million | Q1 2025: $34.72 million | Q2 2025: $36.00 million | Q3 2025: $36.49 million.
- Over the full 9 years of available data (2017 to 2025), InfuSystem Holdings, Inc's Total Revenue has grown by 101.8%.
- Historical annual values: Fiscal year 2025: $143.44 million | Fiscal year 2024: $134.86 million | Fiscal year 2023: $125.79 million | Fiscal year 2022: $109.91 million | Fiscal year 2021: $102.38 million | Fiscal year 2020: $97.39 million | Fiscal year 2019: $81.12 million | Fiscal year 2018: $67.14 million | Fiscal year 2017: $71.08 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: